Both in Pharmaceuticals
Supernus vs Nurix Therapeutics
Over the past year SUPN returned −50.5% and NRIX returned +30.1%; their daily moves had a correlation of 0.17.
SUPN −50.5% NRIX +30.1%Growth of $1, one year, split-adjusted
| Metric | SUPN | NRIX |
|---|---|---|
| Price | $28.21 | $15.95 |
| Market cap | $1.64B | $1.74B |
| Today | +0.21% | −38.23% |
| 1 month | −34.1% | −29.4% |
| 6 months | −45.2% | −5.5% |
| Year to date | −43.2% | −15.9% |
| 1 year | — | +26.4% |
| Revenue growth (YoY) | +18.0% | +8426.3% |
| Gross margin | 88.1% | 100.0% |
| Net margin | 9.2% | 81.7% |
| P/E (TTM) | — | 5.9× |
| Price / sales | 1.9× | 2.5× |
| Net cash | $359.5M | $1.05B |
| Dividend yield | 28.82% | — |
| Volatility (60d) | 86.1% | 104.6% |
| Short % of float | 7.3% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).